J&J says its 1-shot COVID vaccine is effective in trials
Published
The company says it will file for emergency use in the U.S. within a week, with hope its single dose regimen can ease supply and logistics concerns.
Full ArticlePublished
The company says it will file for emergency use in the U.S. within a week, with hope its single dose regimen can ease supply and logistics concerns.
Full ArticleWatch VideoAnother drugmaker is sharing the data that their COVID vaccine works. In clinical trials of more than 43,000 people,..
A single-shot vaccine developed by the healthcare giant Johnson & Johnson is up to 85% effective in preventing the most serious..